GILEAD SCIENCES INC. - US3755581036 (Stock)
/IBT-BA-HP/WEB-INF/snippets/root/general/name.jsp
0
0
0
105,68 USD
|
-0,77% |
15.04.2025 22:00
|
100,00 |
105,80 |
106,21 |
200,00 |
/IBT-BA-HP/WEB-INF/snippets/root/general/v2/infobar.jsp
0
0
0
/IBT-BA-HP/WEB-INF/snippets/root/general/toolbar.jsp
29
1
30
/IBT-BA-HP/WEB-INF/snippets/root/stock/navigation.jsp
34
0
34
Balance ratios |
2024 |
2023 |
Total assets |
58.995.000 USD |
62.125.000 USD |
Employees |
17.600 |
18.000 |
Cash and cash equivalents |
9.991.000 USD |
6.085.000 USD |
Intangible / inalienable assets |
28.262.000 USD |
34.768.000 USD |
Economic shareholder's equity |
19.330.000 USD |
22.833.000 USD |
Subscribed Capital |
1.000 USD |
1.000 USD |
Liabilities |
39.749.000 USD |
39.376.000 USD |
Liabilities to financial institutions |
- |
- |
GuV Zahlen |
2024 |
2023 |
Sales |
28.727.000 USD |
27.058.000 USD |
Profit after tax |
480.000 USD |
5.613.000 USD |
Deprecation (??) |
2.767.000 USD |
2.693.000 USD |
Dividend ordinary shares |
- |
- |
Net investment income |
0 USD |
0 USD |
Dividend preferred shares |
- |
- |
Net interests income |
-696.000 USD |
-568.000 USD |
Earnings from ordinary operating activities |
690.000 USD |
6.859.000 USD |
Net income (after minority interests) |
480.000 USD |
5.665.000 USD |
Net earnings per share |
0.38 USD |
4.5 USD |
Total payout |
3.918.000 USD |
3.809.000 USD |
Administrative expenses |
- |
- |